S. Hædersdal

Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes.

J. Holst, T. Vilsbøll, F. Knop, 2018, American journal of physiology. Gastrointestinal and liver physiology.

GIP and GLP-1 Potentiate Sulfonylurea-Induced Insulin Secretion in Hepatocyte Nuclear Factor 1α Mutation Carriers

T. Hansen, J. Holst, T. Vilsbøll, 2020, Diabetes.

Glimepiride monotherapy versus combination of glimepiride and linagliptin therapy in patients with HNF1A-diabetes: a protocol for a randomised, double-blinded, placebo-controlled trial

T. Hansen, T. Vilsbøll, H. Storgaard, 2018, BMJ Open.

Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA)

T. Hansen, J. Holst, J. Forman, 2020, Diabetes Care.

Impact of lifestyle intervention for obese women during pregnancy on maternal metabolic and inflammatory markers

K. Nørgaard, K. Renault, L. Nilas, 2017, International Journal of Obesity.

Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases

T. Vilsbøll, F. Knop, Andreas Andersen, 2023, Nature Reviews Endocrinology.

The Role of Glucagon in the Acute Therapeutic Effects of SGLT2 Inhibition

J. Holst, T. Vilsbøll, F. Knop, 2020, Diabetes.

The Role of Glucagon in the Pathophysiology and Treatment of Type 2 Diabetes

T. Vilsbøll, F. Knop, A. Lund, 2018, Mayo Clinic proceedings.

Preview : Published ahead of advance online publication Impact of lifestyle intervention for obese women during pregnancy on maternal metabolic and inflammatory markers

K. Nørgaard, T. Halldorsson, L. Nilas, 2017 .